Imricor Medical Systems (ASX:IMR)
ASX announcement history & article coverage
Transparent by design.
Announcments by Imricor Medical Systems (ASX:IMR) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Cleansing Notice
Application for quotation of securities - IMR
Imricor Receives FDA Pediatric Clearances for iMR Device
Imricor obtains FDA clearance for pediatric use of NorthStar system and Vision-MR Diagnostic Catheter
Form S-8 Registration Statement
Submission of the Third PMA Module to the US FDA for Review
Imricor submits third FDA PMA module for MR cardiac ablation devices
Granting of ASX Waiver - US Financial Reporting Requirements
Notification of cessation of securities - IMR
Update - Notification regarding unquoted securities - IMR
Appendix 3Y - AD
Appendix 3Y - PM
Appendix 3Y - AM
Appendix 3Y - MT
Appendix 3Y - SW
Notification regarding unquoted securities - IMR
Becoming a substantial holder
Application for quotation of securities - IMR
Amendment to Form 10
Results of Meeting
Cleansing Notice
Application for quotation of securities - IMR
Release from Voluntary Escrow
AGM Presentation Slides
Chair's Address for AGM
Equity Raising Presentation
Proposed issue of securities - IMR
Imricor Completes Successful A$60 Million Capital Raise
Imricor raises A$60 million to fund U.S. expansion and clinical programs
Trading Halt
Pause in Trading
Imricor Medical Systems Inc. Trading Halt Announced
Imricor Q1 CY26 Quarterly Activities Report and Appendix 4C
Imricor advances FDA approvals, clinical trials, and commercial momentum with US$7.8M Q1 cash outflow
Amendment to Form 10
Imricor files Form 10 amendment; advances MRI-guided cardiac ablation commercialization with FDA clearances and ongoing clinical trials; reports 2025 net loss of $25.3M on early-stage revenues.
Notification regarding unquoted securities - IMR